Back to Search
Start Over
Health Technology Assessment in the Context of Adaptive Pathways for Medicines in Europe: Challenges and Opportunities.
- Source :
- Clinical Pharmacology & Therapeutics; Dec2016, Vol. 100 Issue 6, p594-597, 4p
- Publication Year :
- 2016
-
Abstract
- Adaptive pathways for medicines have gained momentum and, in Europe, adaptive pathways have recently been introduced into the European Medicines Agency (EMA) processes after a successful 2-year pilot. Although the concept, as initially proposed, contained several elements that would have required regulatory reforms, the adaptive pathways program has developed a more pragmatic scope (Box 1). In this article, we explore the main challenges and opportunities adaptive pathways pose from a European health technology assessment (HTA) perspective. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00099236
- Volume :
- 100
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Clinical Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 119456814
- Full Text :
- https://doi.org/10.1002/cpt.448